Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
Perrigo Company | Perrigo | Michigan | state | 2013 | $21,463,000 | | property tax abatement |
Perrigo Company | Perrigo | Michigan | state | 2013 | $14,315,000 | | tax credit/rebate |
Perrigo Company | Perrigo | Michigan | state | 2013 | $2,300,000 | | tax credit/rebate |
Perrigo Company | Perrigo | Michigan | state | 2013 | $2,500,000 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2013 | $495,000 | | grant |
L. Perrigo Company | Perrigo | Michigan | local | 2013 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2013 | undisclosed | | property tax abatement |
Intervet, Inc. | Merck | Delaware | state | 2013 | $16,236 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2013 | $191,000 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $197,815 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2013 | $333,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2013 | $375,037 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2013 | $512,604 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2013 | $2,311,702 | | enterprise zone |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2013 | undisclosed | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | | training reimbursement |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2013 | $83,656 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2013 | $181,443 | | tax credit/rebate |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2013 | $2,500,000 | | federal grant |
Novartis Corporation | Novartis | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2012 | $20,276 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |
Idexx Laboratories, Inc. | IDEXX Laboratories | Tennessee | state | 2012 | $14,400 | | training reimbursement |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $3,239,000 | | grant |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
Mylan Technologies, Inc | Viatris | Vermont | state | 2012 | $4,228,373 | | grant |
C3I, Inc. | Merck | New Hampshire | state | 2012 | $9,105 | | training reimbursement |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | Mississippi | state | 2012 | $50,000 | | training reimbursement |
Genentech USA Inc. | Roche | Oregon | state | 2012 | $3,817,197 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2012 | $15,630 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2012 | $90,531 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2012 | $90,160 | | property tax abatement |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2012 | $1,623 | | property tax abatement |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2012 | $10,263,039 | | tax credit/rebate |
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development, LLC) | Johnson & Johnson | Pennsylvania | state | 2012 | $5,461,142 | | tax credit/rebate |
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2012 | $4,247,696 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2012 | $3,552,766 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2012 | $454,512 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2012 | $342,911 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2012 | $297,513 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2012 | $162,846 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2012 | $160,814 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2012 | $98,234 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2012 | $28,896 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2012 | $24,402 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $12,593 | | tax credit/rebate |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | undisclosed | | training reimbursement |
AMYRIS, INC. | Amyris | California | state | 2012 | $99,927 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | $249,570 | | training reimbursement |
Intervet Inc. | Merck | New Jersey | state | 2012 | $3,981,600 | | grant |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2012 | $627,519 | | property tax abatement |
Merck Animal Health | Merck | Louisiana | state | 2012 | $995,624 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2012 | $409,319 | | property tax abatement |
Alexion Pharmaceuticals | AstraZeneca | Connecticut | state | 2012 | $51,000,000 | | tax credit/rebate |
PFIZER INC | Pfizer | New York | local | 2012 | $228,420 | | property tax abatement |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $695,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $300,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2012 | $45,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $1,380,000 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2012 | $195,000 | | grant |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2012 | $5,369,069 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $45,000 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $49,500 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $85,700 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $91,500 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $347,213 | | tax credit/rebate |
Mallinckrodt Enterprises | Mallinckrodt | North Carolina | state | 2012 | $441,576 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $2,467,398 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $6,651,352 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2012 | $3,274 | | tax credit/rebate |
Alpharma Specialty Pharma, Inc. | Pfizer | North Carolina | state | 2012 | $3,885 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2012 | $3,891 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2012 | $5,319 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2012 | $5,602 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2012 | $12,443 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2012 | $13,576 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2012 | $15,915 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2012 | $16,858 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2012 | $20,827 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2012 | $32,718 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2012 | $54,345 | | tax credit/rebate |